U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.391T>C (p.Ser131Pro) AND Maturity-onset diabetes of the young type 2

Germline classification:
Likely pathogenic (3 submissions)
Last evaluated:
Aug 2, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000017518.33

Allele description [Variation Report for NM_000162.5(GCK):c.391T>C (p.Ser131Pro)]

NM_000162.5(GCK):c.391T>C (p.Ser131Pro)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.391T>C (p.Ser131Pro)
HGVS:
  • NC_000007.14:g.44151048A>G
  • NG_008847.2:g.52123T>C
  • NM_000162.5:c.391T>CMANE SELECT
  • NM_001354800.1:c.391T>C
  • NM_033507.3:c.394T>C
  • NM_033508.3:c.388T>C
  • NP_000153.1:p.Ser131Pro
  • NP_001341729.1:p.Ser131Pro
  • NP_277042.1:p.Ser132Pro
  • NP_277043.1:p.Ser130Pro
  • LRG_1074t1:c.391T>C
  • LRG_1074t2:c.394T>C
  • LRG_1074:g.52123T>C
  • LRG_1074p1:p.Ser131Pro
  • LRG_1074p2:p.Ser132Pro
  • NC_000007.13:g.44190647A>G
  • NM_000162.3:c.391T>C
  • P35557:p.Ser131Pro
Protein change:
S130P; SER131PRO
Links:
UniProtKB: P35557#VAR_003697; OMIM: 138079.0007; dbSNP: rs104894010
NCBI 1000 Genomes Browser:
rs104894010
Molecular consequence:
  • NM_000162.5:c.391T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.391T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.394T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.388T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Maturity-onset diabetes of the young type 2
Synonyms:
MODY type 2; Diabetes mellitus MODY type 2; MODY glucokinase-related; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007453; MedGen: C0342277; Orphanet: 552; OMIM: 125851

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000037790OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 1993)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV002562171Geisinger Clinic, Geisinger Health System
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Aug 2, 2022)
germlineresearch

PubMed (2)
[See all records that cite these PMIDs]

SCV003835349Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jul 1, 2022)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineyes1not providednot providednot providednot providedresearch
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of glucokinase mutations in subjects with gestational diabetes mellitus.

Stoffel M, Bell KL, Blackburn CL, Powell KL, Seo TS, Takeda J, Vionnet N, Xiang KS, Gidh-Jain M, Pilkis SJ, et al.

Diabetes. 1993 Jun;42(6):937-40.

PubMed [citation]
PMID:
8495817

Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts.

Mirshahi UL, Colclough K, Wright CF, Wood AR, Beaumont RN, Tyrrell J, Laver TW, Stahl R, Golden A, Goehringer JM; Geisinger-Regeneron DiscovEHR Collaboration., Frayling TF, Hattersley AT, Carey DJ, Weedon MN, Patel KA.

Am J Hum Genet. 2022 Nov 3;109(11):2018-2028. doi: 10.1016/j.ajhg.2022.09.014. Epub 2022 Oct 17.

PubMed [citation]
PMID:
36257325
PMCID:
PMC9674944
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000037790.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Stoffel et al. (1993) found heterozygosity for a ser131-to-pro mutation in the GCK gene in an obese 31-year-old Puerto Rican woman with gestational diabetes (MODY2; 125851) in her first pregnancy. She reportedly had borderline elevated blood glucose levels at age 26. Stoffel et al. (1993) showed defective enzymatic properties of the enzyme carrying the ser131-to-pro mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Geisinger Clinic, Geisinger Health System, SCV002562171.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (2)

Description

PM2, PP1_Strong, PP4, PP2, PS3_Supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From Baylor Genetics, SCV003835349.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024